Quadria Capital is exploring options to sell its stake in Encube Ethicals. The healthcare investor considers both a controlling stake sale and an IPO. Encube Ethicals, a dermatology firm, is valued at $2.2 billion. KKR, Blackstone, and EQT show interest in acquiring a stake. JP Morgan is already mandated for the sale.